- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 29, 2025 | 95.14M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $599.78M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $788.42M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.62B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.73B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.3B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.37B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 87.03M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $684K |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | $44.34M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $612.8M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $635.31M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.74 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.74 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $57.61M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $63.09M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$64.6M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$67.47M |